8. clinical presentation

Upload: venus-lorraine-biaca-datud

Post on 03-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/29/2019 8. Clinical Presentation

    1/20

    CLINICALCLINICAL

  • 7/29/2019 8. Clinical Presentation

    2/20

    Wide range of symptoms and signs isWide range of symptoms and signs is

    related to:related to:

    1. Histologic features which often help determinethe anatomic site of origin in the lung

    2. The specific tumor location in the lung and itsrelationship to surrounding structures

    3. Biologic features and the production of avariety of paraneoplastic syndromes

    4. The presence or absence of metastatic disease

  • 7/29/2019 8. Clinical Presentation

    3/20

    Clinical Presentation of Lung CancerClinical Presentation of Lung Cancer

    Pulmonary symptoms

    Cough Bronchus irritation orcompression

    Dyspnea Airway obstruction orcompression

    Wheezing >50% airway obstruction

  • 7/29/2019 8. Clinical Presentation

    4/20

    Nonpulmonary thoracic symptomsHemoptysis Tumor erosion or irritation

    Pneumonia Airway obstruction

    Pleuritic pain Parietal pleural irritation or invasion

    Local chest Rib and/or muscle involvement

    wall pain

  • 7/29/2019 8. Clinical Presentation

    5/20

    Radicular chest pain Intercostal nerve involvement

    Pancoast's syndrome Stellate ganglion, chest wall,brachial

    plexus involvement

    Hoarseness Recurrent laryngeal nerveinvolvement

    Swelling of head and arms :1.Bulky involved mediastinal

    lymph nodes

    2.Medially based right upper lobe

  • 7/29/2019 8. Clinical Presentation

    6/20

    TUMOR HISTOLOGYTUMOR HISTOLOGY

    Squamous cell and small cell carcinomas:Arise in main lobar, or first

    segmental bronchi{centralairways}

    Adenocarcinomas: located peripherally,Asymptomatic peripheral lesion on chest

    radiograph

    BAC : solitary nodule, as multifocal nodules, or as a

    diffuse infiltrate mimicking(PNEUMONIC FORM)air bronchograms may be seen radiographically

    within the tumor

  • 7/29/2019 8. Clinical Presentation

    7/20

    SITE OF TUMORS

    Squamous cell = 66% occur centrally in lunghilus(sq=central)

    Adenocarcinoma = Peripheral,

    Small (oat) cell = Central, highly malignant,usually not operable

    Large cell = Usually peripheral, verymalignant

  • 7/29/2019 8. Clinical Presentation

    8/20

  • 7/29/2019 8. Clinical Presentation

    9/20

    Nonpulmonary Thoracic Symptoms

    OCCURS DUE TO invasion of the primary tumor directlyinto a contiguous structure or from mechanicalcompression of a structure by enlarged tumor-bearinglymph nodes

    Peripherally located tumors ( adenocarcinomas)extending through the visceral pleura lead to irritationor growth into the parietal pleura and to continuedgrowth into the chest wall structures

    SYMPTOMS depending on the extent of chest wall

    involvement1.pleuritic pain

    2.localized chest wall pain

    3.radicular pain

  • 7/29/2019 8. Clinical Presentation

    10/20

    Superior sulcus tumors (usuallyadenocarcinomas)

    may produce the Pancoast syndromeTumoratthe apex of the lung or superior sulcus that mayinvolve the brachial plexus, sympathetic ganglia,

    and vertebral bodies, leading to pain, upperextremity weakness, and

    Horners syndrome

    Injury to the cervical sympathetic chain(MAP)

    1. Miosis (small pupil)

    2. Anhydrosis of ipsilateral face

    3. Ptosis

    Depending on the exact tumor location, symptoms

    can include

  • 7/29/2019 8. Clinical Presentation

    11/20

    Invasion of the primary tumor into the mediastinummay lead to involvement of the phrenic or recurrent laryngealnerves. Direct invasion of the phrenic nerve occurs withtumors of the medial surface of the lung, or with anterior hilartumors.

    Symptoms may include

    1.shoulder pain (referred),

    2.hiccups, and dyspnea with exertion

    Because of diaphragm paralysis

    Diagnosis;chest radiograph,fluoroscopic examination of thediaphragm and with breathing and sniffing (the sniff test)

  • 7/29/2019 8. Clinical Presentation

    12/20

    Recurrent laryngeal nerve (RLN)

    most commonly occurs on the left side.

    Paralysis may occur

    1. invasion of the vagus nerve above the aortic arch by amedially based left upper lobe (LUL) tumor,

    2.invasion of the RLN directly by a hilar tumor,

    3.invasion by hilar or aortopulmonary lymph nodes

    involved with metastatic tumor.

  • 7/29/2019 8. Clinical Presentation

    13/20

    Symptoms:

    Voice change,often referred to as hoarseness,

    Loss of tone associated with a breathy quality,

    Coughing( when drinking liquids)

  • 7/29/2019 8. Clinical Presentation

    14/20

    Tumor BiologyTumor Biology

    Lung cancers both nonsmall-cell andsmall-cellcarcinoma

    Capable of producing a variety of paraneoplasticsyndrome

    Most often from tumor production and release ofbiologically active materials systemically.

    Majority ofsuch syndromes are caused by small-cellcarcinomas, including many endocrinopathies.

  • 7/29/2019 8. Clinical Presentation

    15/20

    Paraneoplastic syndromes

    Early diagnosis. Presence does not influence resectabilityor the potential to successfully treat the tumor.

    Symptoms of the syndrome often will abate with

    successful treatment, and recurrence may be heraldedby recurrent paraneoplastic symptoms.

    5 general types of paraneoplastic syndromes.

    1. Metabolic: Cushings, SIADH, hypercalcemia

    2. Neuromuscular: Eaton-Lambert,cerebellar ataxia3. Skeletal: hypertrophic osteoarthropathy

    4. Dermatologic: acanthosis nigricans

    5. Vascular: thrombophlebitis

  • 7/29/2019 8. Clinical Presentation

    16/20

    SCLC :: hypertrophic pulmonaryosteoarthropathy (HPO)

    Most common paraneoplasticsyndromes

    Syndrome is characterized by tenderness andswelling of the ankles, feet, forearms, and hands.

    Because of periostitis of the fibula, tibia, radius,metacarpals, and metatarsals.

  • 7/29/2019 8. Clinical Presentation

    17/20

    HypercalcemiaHypercalcemia

    10% of patients with lung cancer and is most oftenbecause of metastatic disease

    15 % of cases are because of secretion of ectopicparathyroid hormonerelated peptide, most often

    with squamous cell carcinoma

    Diagnosis of ectopic parathyroid hormone secretioncan be made by measuring elevated serum levels

    of parathyroid hormone; the clinician must also ruleout concurrent metastatic bone disease by a bonescan.

  • 7/29/2019 8. Clinical Presentation

    18/20

    Metastatic SymptomsMetastatic Symptoms

    METASTASES occur most commonly

    Central nervous system (CNS),

    Vertebral bodies,

    Bones,Liver,

    Adrenal glands,

    Lungs,Skin and Soft tissues.

    10 % of patients with lung cancer have CNSmetastases

    1015 %will develop CNS metastases

    SYMPTOMS: headache, nausea and vomiting,

    seizures, hemiplegia, and speech difficulty.

  • 7/29/2019 8. Clinical Presentation

    19/20

    Nonspecific SymptomsNonspecific Symptoms

    Lung cancer often produces a variety ofnonspecific symptoms such as

    Anorexia

    Weight loss

    Fatigue

    Malaise

    The cause of these symptoms is oftenunclear, should raiseconcern about possible metastatic disease

  • 7/29/2019 8. Clinical Presentation

    20/20

    END............................................................